Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism

PLoS One. 2013 Jun 28;8(6):e67417. doi: 10.1371/journal.pone.0067417. Print 2013.

Abstract

Background: Historically, urinary aldosterone level measurement was a commonly employed confirmatory test to detect primary aldosteronism (PA). However, 24-h urine collection is inconvenient and cumbersome. We hypothesized that random urinary aldosterone measurements with correction for creatinine concentration might be comparable to 24-h urinary aldosterone levels (Uald-24 h) in the diagnosis of PA.

Methods: The non-concurrent prospective study was conducted between June 2006 and March 2008 in patients admitted for confirmation of aldosteronism by salt loading test. A 24-h urine sample, which was collected during hospitalization on the day before saline infusion testing after restoration of serum hypokalemia, was collected from all subjects. Moreover, participants were asked to collect a first bladder voiding random urine sample during clinic visits. Uald-24 h and the random urinary aldosterone-to-creatinine ratio (UACR) were calculated accordingly.

Results: A total of 102 PA patients (71 patients diagnosed of aldosterone-producing adenoma, 31 with idiopathic hyperaldosteronism) and 65 patients with EH were enrolled. The receiver operating characteristic curve showed comparable areas under the curves of UACR and Uald-24 h. The Bland-Altman plot showed mean bias but no obvious heteroscedasticity between the two tests. When using random UACR >3.0 ng/mg creatinine as the cutoff value, we obtained a specificity of 90.6% to confirm PA from essential hypertension.

Conclusions: Our study reinforce that the diagnostic accuracy of random UACR was comparable to that of Uald-24 h in PA patients. With the quickness and simplicity of the UACR method and its equivalence to Uald-24 h, this assay could be a good alternative diagnostic tool for PA confirmation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / complications
  • Adenoma / urine*
  • Adrenal Gland Neoplasms / complications
  • Adrenal Gland Neoplasms / urine*
  • Adult
  • Aldosterone / urine*
  • Creatinine / urine*
  • Essential Hypertension
  • Female
  • Humans
  • Hyperaldosteronism / diagnosis*
  • Hyperaldosteronism / etiology
  • Hyperaldosteronism / urine*
  • Hypertension / urine
  • Male
  • Middle Aged
  • Prospective Studies
  • ROC Curve

Substances

  • Aldosterone
  • Creatinine

Grants and funding

This study was supported by Taiwan National Science Council (grants 5 NSC101-2314-B-002-132-MY3, NSC100-2314-B-002-119, and NSC6 101-2314-B-002-085-MY3) and National Taiwan University Hospital, 100-N1776, 101-M1953, and 102-S2097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.